Načítá se...
Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities
The COVID-19 pandemic affected many activities in the healthcare system including oncology drug development. Clinical trial recruitment was temporary halted in many centres to reduce patients and healthcare workers’ potential exposure to the virus. Conversely, to continue offering treatments for pat...
Uloženo v:
| Vydáno v: | Cancer Treat Rev |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier Ltd.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7286270/ https://ncbi.nlm.nih.gov/pubmed/32544543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2020.102047 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|